InternationalUSRemember you can easily switch between MIP US and MIP International at any time

ANDA pharma litigation spikes back up in 2017

Michael Loney, New York


After a slump in 2016, US pharmaceutical patent litigation triggered by the Hatch-Waxman process rose to 411 cases last year

Last year 411 ANDA cases were filed in the US, up from 318 in 2016, reveals Lex Machina’s recently released Patent Litigation Year in Review report.

This meant ANDA litigation moved closer to the peak levels seen in 2014...


Please log in to read the rest of this article.

New to Managing Intellectual Property? Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.

Already registered?

Please make sure you log in to read the rest of the article.

Log in

Join us now

Gain FREE access to up to five free articles when you register now.

Join here

More from the Managing IP blog


null null null

nullnullnull

null

May / June 2019

From trademarks to trade secrets: in-house tips on brand protection in China

Despite the well-known struggles in protecting trademarks and trade secrets in China, there are some tried-and-tested strategies to employ, as Karry Lai and Ellie Mertens hear from in-house counsel at a range of domestic and international companies



Most read articles

Supplements